Published in Women's Health Weekly, September 7th, 2006
"The aim of this study was to explore how to modulate the expression of ER alpha and beta and to verify the role of ER alpha and beta in relationship to estrogen and tamoxifen (TAM)," wrote Y. Zhang and colleagues, Peking University First Hospital.
"A series of oligodeoxyribonucleotides (ODN) corresponding to regions of the ER alpha or beta was tested in human endometrial cancer cell lines (HEC-1B). The change in HEC-1B...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly